EVA ANETTE ENGELHARDT
CIK 2024911 · EVP, President, CDG · last filed 2026-07-28
EVA ANETTE ENGELHARDT is an EVP, President, CDG who has filed 8 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for BIO.B, was dated Jul 28, 2026. Across all open-market trades the lifetime net is −$135.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $169.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$169.5K
1
8
-$135.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIO.B | EVP, President, CDG | 503 | $337.00 | $169.5K | -$135.6K | 7 | 2026-07-28 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-28 | BIO.B | Mixed | +157 | -$28.0K | EDGAR |
| 2026-05-13 | BIO.B | Sell (S) | −550 | -$135.6K | EDGAR |
| 2026-05-11 | BIO | Notice (144) | −550 | -$135.6K | EDGAR |
| 2025-09-09 | BIO.B | Mixed | +739 | -$122.0K | EDGAR |
| 2025-07-29 | BIO.B | Mixed | +157 | -$23.2K | EDGAR |
| 2025-03-05 | BIO.B | Grant (A) | — | $0 | EDGAR |
| 2024-09-10 | BIO.B | Grant (A) | — | $0 | EDGAR |
| 2024-07-29 | BIO.B | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.